サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1311096

線維筋痛症治療の世界市場規模調査＆予測：薬効クラス別、流通チャネル別、地域別分析、2023-2030年

Global Fibromyalgia Treatment Market Size study & Forecast, by Drug Class, by Distribution Channel and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
線維筋痛症治療の世界市場規模調査＆予測：薬効クラス別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年07月11日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の線維筋痛症治療市場は、2022年に約31億米ドルと評価され、予測期間2023-2030年には4.0％以上の健全な成長率で成長すると予測されています。

線維筋痛症治療市場は、慢性疼痛疾患である線維筋痛症に関連する症状の管理と緩和を目的とした治療的介入と薬剤の開拓と利用に焦点を当てたセグメントを指します。この市場には、鎮痛薬、抗うつ薬、抗けいれん薬などの薬理学的介入や、理学療法、認知行動療法、補完代替療法などの非薬理学的アプローチなど、さまざまな治療法が含まれます。線維筋痛症治療市場は、疼痛の軽減、睡眠の改善、疲労の管理、その他の関連症状への対処により、線維筋痛症患者の生活の質を改善する効果的なソリューションを提供することを目的としています。線維筋痛症治療市場は、線維筋痛症やその治療に関する認知度の急上昇、線維筋痛症治療のためのジェネリック医薬品へのアクセス強化といった要因によって牽引されています。

線維筋痛症治療には、線維筋痛症患者の症状を管理し、生活の質を向上させることを目的とした多角的なアプローチが含まれます。米国国立関節炎・筋骨格系・皮膚疾患研究所によると、米国では18歳以上の約500万人が線維筋痛症に苦しんでいます。また、線維筋痛症患者の80～90％以上が女性です。また、ルピンは2022年5月、神経障害性疼痛、線維筋痛症、てんかんの治療に使用されるリリカカプセルの代替品であるプレガバリンカプセルのジェネリック医薬品のFDA承認を取得しました。このカプセルは様々な強さのものがあり、インドのルピンのアウランガバード工場で製造されます。今回の承認により、ルピンはリリカの代替品をより手頃な価格で提供できるようになり、米国における必須治療薬へのアクセスが拡大します。このように、線維筋痛症例とFDA承認の増加は、市場の成長を後押ししています。また、線維筋痛症治療のパイプラインが充実しており、新規治療薬の市場開拓が進んでいることも、同市場に有利な機会をもたらす可能性があります。しかし、代替治療オプションの利用可能性は、2023年から2030年の予測期間を通じて市場の成長を妨げる可能性があります。

線維筋痛症治療の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は2022年に市場を独占したが、これは同地域における線維筋痛症の高い有病率の増加、慢性疼痛状態に罹患している人数の多さ、治療オプションの進歩によるものです。アジア太平洋地域は、ヘルスケア施設への投資の増加とヘルスケア技術の進歩により、予測期間中に最も急速に成長する地域と考えられています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 線維筋痛症治療市場：地域別、2020-2030年
    • 線維筋痛症治療市場：薬効クラス別、2020-2030年
    • 線維筋痛症治療市場：流通チャネル別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提

第2章 線維筋痛症治療の世界市場定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 線維筋痛症治療の世界市場力学

  • 線維筋痛症治療市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • 線維筋痛症に関する認知度の急上昇
      • 線維筋痛症治療のジェネリック医薬品へのアクセス向上
    • 市場の課題
      • 代替治療オプションの利用可能性。
    • 市場機会
      • 線維筋痛症治療の充実したパイプライン。
      • 新規治療法の開発。

第4章 線維筋痛症治療の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 線維筋痛症治療の世界市場：薬効クラス別

  • 市場スナップショット
  • 線維筋痛症治療の世界市場：薬効クラス別、実績-潜在能力分析
  • 線維筋痛症治療の世界市場：薬効クラス別推定・予測、2020-2030年
  • 線維筋痛症治療市場、サブセグメント分析
    • 抗うつ薬
    • 抗痙攣薬
    • 筋弛緩薬
    • その他

第6章 線維筋痛症治療の世界市場：流通チャネル別

  • 市場スナップショット
  • 線維筋痛症治療の世界市場：流通チャネル別、実績-潜在能力分析
  • 線維筋痛症治療の世界市場：流通チャネル別推定・予測2020ー2030年
  • 線維筋痛症治療市場のサブセグメント分析
    • ホスピタリティ薬局
    • ドラッグストアおよび小売薬局
    • オンラインプロバイダー

第7章 線維筋痛症治療の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 線維筋痛症治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬効分類の推定・予測、2020-2030年
      • 流通チャネルの推定・予測、2020-2030年
    • カナダ
  • 欧州線維筋痛症治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋線維筋痛症治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ線維筋痛症治療市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • AbbVie Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Teva Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals LLC
    • Novartis AG
    • Zydus Lifesciences Limited
    • Viatris Inc.
    • Eli Lilly and Company
    • Sun Pharmaceutical Industries Limited
    • Abbott Laboratories
    • Lupin Limited

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Fibromyalgia Treatment Market, report scope
  • TABLE 2. Global Fibromyalgia Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Fibromyalgia Treatment Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
  • TABLE 4. Global Fibromyalgia Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 5. Global Fibromyalgia Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Fibromyalgia Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Fibromyalgia Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Fibromyalgia Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Fibromyalgia Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Fibromyalgia Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Fibromyalgia Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Fibromyalgia Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Fibromyalgia Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Fibromyalgia Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Fibromyalgia Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Fibromyalgia Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Fibromyalgia Treatment Market
  • TABLE 70. List of primary sources, used in the study of global Fibromyalgia Treatment Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Fibromyalgia Treatment Market, research methodology
  • FIG 2. Global Fibromyalgia Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Fibromyalgia Treatment Market, key trends 2022
  • FIG 5. Global Fibromyalgia Treatment Market, growth prospects 2023-2030
  • FIG 6. Global Fibromyalgia Treatment Market, porters 5 force model
  • FIG 7. Global Fibromyalgia Treatment Market, pest analysis
  • FIG 8. Global Fibromyalgia Treatment Market, value chain analysis
  • FIG 9. Global Fibromyalgia Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Fibromyalgia Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Fibromyalgia Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Fibromyalgia Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Fibromyalgia Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Fibromyalgia Treatment Market, regional snapshot 2020 & 2030
  • FIG 15. North America Fibromyalgia Treatment Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Fibromyalgia Treatment Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Fibromyalgia Treatment Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Fibromyalgia Treatment Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Fibromyalgia Treatment Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Fibromyalgia Treatment Market is valued at approximately USD 3.1 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.0% over the forecast period 2023-2030. The fibromyalgia treatment market refers to a segment focused on the development and utilization of therapeutic interventions and medications aimed at managing and alleviating the symptoms associated with fibromyalgia, a chronic pain disorder. This market encompasses various treatment modalities, including pharmacological interventions, such as pain medications, antidepressants, and anticonvulsants, as well as non-pharmacological approaches such as physical therapy, cognitive-behavioral therapy, and complementary and alternative therapies. The fibromyalgia treatment market aims to provide effective solutions to improve the quality of life for individuals living with fibromyalgia by reducing pain, improving sleep, managing fatigue, and addressing other associated symptoms. The Fibromyalgia Treatment Market is being driven by factors such as a surge in awareness regarding fibromyalgia and its treatment and Enhanced access to generic medications for fibromyalgia treatment.

Fibromyalgia treatment involves a multidimensional approach aimed at managing the symptoms and improving the quality of life for individuals with fibromyalgia. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, approximately five million individuals aged 18 years or over in the U.S. suffer from fibromyalgia. Additionally, over 80-90 %of fibromyalgia patients are female. Along with that Lupin has received FDA approval on May 2022, for its generic Pregabalin Capsules, a substitute for Lyrica Capsules used to treat neuropathic pain, fibromyalgia, and epilepsy. The capsules, available in various strengths, will be manufactured in Lupin's Aurangabad facility in India. This approval allows Lupin to offer a more affordable alternative to Lyrica, expanding access to essential medication in the United States. Thus, these fibromyalgia cases and increasing FDA approvals fuel the growth of the market. In addition to Robust pipeline of products for fibromyalgia treatment and the development of novel therapies may create lucrative opportunities for the market. However, the availability of alternative treatment options may hinder the growth of the market throughout the forecast period of 2023-2030.

The key regions considered for the Global Fibromyalgia Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to an increase in the high prevalence of Fibromyalgia in the region, with a significant number of individuals affected by the chronic pain condition and advancements in treatment options. Asia Pacific is considered the fastest growing region during the forecasted period due to increasing investment in healthcare facility and advancement in healthcare technologies.

Major market player included in this report are:

  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals LLC
  • Novartis AG
  • Zydus Lifesciences Limited
  • Viatris Inc.
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Limited
  • Abbott Laboratories
  • Lupin Limited.

Recent Developments in the Market:

  • In January 2023, Amneal Pharmaceuticals, Inc. recently entered into a long-term license agreement with Orion Corporation. This strategic partnership grants Amneal Pharmaceuticals the commercialization rights for multiple complex generic products in the European, Australian, and New Zealand markets. With this agreement, Amneal Pharmaceuticals gains the opportunity to introduce and market its innovative generic products in these regions, expanding its global presence and providing patients with access to high-quality and cost-effective treatment options. The collaboration with Orion Corporation strengthens Amneal's position as a leading player in the pharmaceutical industry and reinforces its commitment to delivering affordable healthcare solutions to a wider patient population.

Global Fibromyalgia Treatment Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered -Drug Class, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug class:

  • Antidepressants
  • Anticonvulsants
  • Muscle Relaxants
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Drug stores and retail pharmacies
  • Online providers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Fibromyalgia Treatment Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Fibromyalgia Treatment Market, by Drug Class, 2020-2030 (USD Billion)
    • 1.2.3. Fibromyalgia Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Fibromyalgia Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Fibromyalgia Treatment Market Dynamics

  • 3.1. Fibromyalgia Treatment Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surge in awareness regarding fibromyalgia.
      • 3.1.1.2. Improve access to generic fibromyalgia medications.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of alternate treatment options.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Robust pipeline of products for fibromyalgia treatment.
      • 3.1.3.2. Development of novel therapies.

Chapter 4. Global Fibromyalgia Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Fibromyalgia Treatment Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Fibromyalgia Treatment Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Fibromyalgia Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
  • 5.4. Fibromyalgia Treatment Market, Sub Segment Analysis
    • 5.4.1. Antidepressants
    • 5.4.2. Anticonvulsants
    • 5.4.3. Muscle Relaxants
    • 5.4.4. Others

Chapter 6. Global Fibromyalgia Treatment Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Fibromyalgia Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Fibromyalgia Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 6.4. Fibromyalgia Treatment Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Drug stores and retail pharmacies
    • 6.4.3. Online providers

Chapter 7. Global Fibromyalgia Treatment Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Fibromyalgia Treatment Market, Regional Market Snapshot
  • 7.4. North America Fibromyalgia Treatment Market
    • 7.4.1. U.S. Fibromyalgia Treatment Market
      • 7.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Fibromyalgia Treatment Market
  • 7.5. Europe Fibromyalgia Treatment Market Snapshot
    • 7.5.1. U.K. Fibromyalgia Treatment Market
    • 7.5.2. Germany Fibromyalgia Treatment Market
    • 7.5.3. France Fibromyalgia Treatment Market
    • 7.5.4. Spain Fibromyalgia Treatment Market
    • 7.5.5. Italy Fibromyalgia Treatment Market
    • 7.5.6. Rest of Europe Fibromyalgia Treatment Market
  • 7.6. Asia-Pacific Fibromyalgia Treatment Market Snapshot
    • 7.6.1. China Fibromyalgia Treatment Market
    • 7.6.2. India Fibromyalgia Treatment Market
    • 7.6.3. Japan Fibromyalgia Treatment Market
    • 7.6.4. Australia Fibromyalgia Treatment Market
    • 7.6.5. South Korea Fibromyalgia Treatment Market
    • 7.6.6. Rest of Asia Pacific Fibromyalgia Treatment Market
  • 7.7. Latin America Fibromyalgia Treatment Market Snapshot
    • 7.7.1. Brazil Fibromyalgia Treatment Market
    • 7.7.2. Mexico Fibromyalgia Treatment Market
  • 7.8. Middle East & Africa Fibromyalgia Treatment Market
    • 7.8.1. Saudi Arabia Fibromyalgia Treatment Market
    • 7.8.2. South Africa Fibromyalgia Treatment Market
    • 7.8.3. Rest of Middle East & Africa Fibromyalgia Treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. AbbVie Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Teva Pharmaceutical Industries Ltd.
    • 8.3.3. Amneal Pharmaceuticals LLC
    • 8.3.4. Novartis AG
    • 8.3.5. Zydus Lifesciences Limited
    • 8.3.6. Viatris Inc.
    • 8.3.7. Eli Lilly and Company
    • 8.3.8. Sun Pharmaceutical Industries Limited
    • 8.3.9. Abbott Laboratories
    • 8.3.10. Lupin Limited

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption